Voyageur Pharmaceuticals Ltd (VM) - Cash Flow Conversion Efficiency

Latest as of November 2025: -0.295x

Based on the latest financial reports, Voyageur Pharmaceuticals Ltd (VM) has a cash flow conversion efficiency ratio of -0.295x as of November 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-369.98K ≈ $-267.64K USD) by net assets (CA$1.25 Million ≈ $906.00K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Voyageur Pharmaceuticals Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Voyageur Pharmaceuticals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read VM total liabilities for a breakdown of total debt and financial obligations.

Voyageur Pharmaceuticals Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Voyageur Pharmaceuticals Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
CAM Resources Bhd KLSE:7128	0.149x
Omineca Mining and Metals Ltd V:OMM	-0.046x
Hampton Financial Corp V:HFC	-1.435x
JOY SPREADER GROUP INC. F:5YN	N/A
Polyrizon Ltd. Ordinary Shares NASDAQ:PLRZ	-0.099x
Glen Burnie Bancorp NASDAQ:GLBZ	0.020x
Grand Baoxin Auto Group Limited F:6BA	-0.007x
Vo2 Cap Holding AB ST:VO2	0.070x

Annual Cash Flow Conversion Efficiency for Voyageur Pharmaceuticals Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Voyageur Pharmaceuticals Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see Voyageur Pharmaceuticals Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-11-30	CA$1.25 Million ≈ $906.00K	CA$-2.89 Million ≈ $-2.09 Million	-2.310x	-243.80%
2024-11-30	CA$449.96K ≈ $325.49K	CA$-302.29K ≈ $-218.67K	-0.672x	+2.69%
2023-11-30	CA$1.44 Million ≈ $1.04 Million	CA$-991.25K ≈ $-717.06K	-0.690x	+41.17%
2022-11-30	CA$1.46 Million ≈ $1.06 Million	CA$-1.72 Million ≈ $-1.24 Million	-1.174x	-35.22%
2021-11-30	CA$1.91 Million ≈ $1.38 Million	CA$-1.65 Million ≈ $-1.20 Million	-0.868x	+2.33%
2020-11-30	CA$306.33K ≈ $221.60K	CA$-272.19K ≈ $-196.90K	-0.889x	-5.05%
2019-11-30	CA$754.09K ≈ $545.50K	CA$-637.81K ≈ $-461.38K	-0.846x	+11.07%
2018-11-30	CA$515.68K ≈ $373.04K	CA$-490.45K ≈ $-354.79K	-0.951x	-113.60%
2017-11-30	CA$-89.24K ≈ $-64.55K	CA$-624.24K ≈ $-451.56K	6.995x	+13473.35%
2016-11-30	CA$670.46K ≈ $485.00K	CA$-35.07K ≈ $-25.37K	-0.052x	+94.07%
2015-11-30	CA$80.07K ≈ $57.92K	CA$-70.65K ≈ $-51.11K	-0.882x	-204.17%
2014-11-30	CA$81.56K ≈ $59.00K	CA$-23.66K ≈ $-17.11K	-0.290x	+6.71%
2013-11-30	CA$176.02K ≈ $127.33K	CA$-54.73K ≈ $-39.59K	-0.311x	-3070.28%
2012-11-30	CA$221.34K ≈ $160.12K	CA$2.32K ≈ $1.68K	0.010x	+106.87%
2011-11-30	CA$185.00K ≈ $133.83K	CA$-28.19K ≈ $-20.39K	-0.152x	--

About Voyageur Pharmaceuticals Ltd

V:VM Canada Drug Manufacturers - Specialty & Generic

Market Cap

$14.21 Million

CA$19.64 Million CAD

Market Cap Rank

#25996 Global

#1059 in Canada

Share Price

CA$0.11

Change (1 day)

+0.00%

52-Week Range

CA$0.10 - CA$0.34

All Time High

CA$0.34